Contagion Editorial Staff

Justin R. Anderson, PhD, associate professor of biology at Radford University, describes his research on the effects of endocrine disrupting chemicals on mosquito-borne viruses.

Kirk Hevener, PharmD, PhD, explains the importance of narrow-spectrum antibacterial targets.

Romney Humphries, PhD, D(ABMM), discusses new technologies to detect antimicrobial susceptibility and resistance that are currently under production.

Craig Rubens, MD, PhD, co-founder and executive director of GAPPS at Seattle Children’s Hospital, describes the current disease burden of neonatal infections across the globe.

Andrew Chasteen from Accelerate Diagnostics, Inc, explains Morphokinetic Cellular Analysis (MCA) and how it differs from other analyses.

Prof. Andrea Endimiani, MD, PhD, from the Institute of Infectious Diseases at the University of Bern, Switzerland, explains which pathogens are most affected by the colistin resistant mcr-1 gene.

John Mohr, PharmD, president and founder of Medical Affairs Strategic Solutions, LLC, explains the current state of the antimicrobial pipeline.

Monica Mahoney, PharmD, BCPS-AQ ID, clinical pharmacy coordinator of infectious diseases at Beth Israel Deaconess Medical Center, explains the antimicrobial considerations that are specific to the solid organ transplant population.

Emily Heil, PharmD, BCPS-AQ ID, from the University of Maryland School of Pharmacy, discusses the concerns of antibiotic use in agriculture.

Jason C. Gallagher, PharmD, president, Society of Infectious Diseases Pharmacists, explains if we know how the case of mcr-1 E. coli superbug was contracted.

Marion A. Kainer, MD, MPH, FRACP, FSHEA, Director of Healthcare Associated Infection and Antimicrobial Resistance Program, Tennessee Department of Health, discusses some of the key points to aid in the fight against healthcare associated infections, nationwide.

Jason C. Gallagher, PharmD, President, Society of Infectious Diseases Pharmacists describes the recent case of an antibiotic resistant “superbug” in Pennsylvania.

Marion A. Kainer, MD, MPH, FRACP, FSHEA, Director, Healthcare Associated Infections and Antimicrobial Resistance Program, Tennessee Department of Health, explains how the CDC aid state health departments in the fight against healthcare associated infections.

Christina G. Tan, MD, MPH, FACP, New Jersey State Epidemiologist/Assistant Commissioner, outlines New Jersey Department of Health’s role in vaccine awareness.

Christina G. Tan, MD, MPH, FACP, New Jersey State Epidemiologist/Assistant Commissioner, provides background on New Jersey Department of Health’s Zika prevention program, ZAP Zika.

Christina G. Tan, MD, MPH, FACP, New Jersey State Epidemiologist/Assistant Commissioner, examines the probability of a Zika outbreak in New Jersey.

Christina G. Tan, MD, MPH, FACP, New Jersey State Epidemiologist/Assistant Commissioner, explains how health care practitioners can aid in the prevention of Zika virus infections.

Christina G. Tan, MD, MPH, FACP, New Jersey State Epidemiologist/Assistant Commissioner, discusses Zika vector prevalence and infection prevention in New Jersey

Health officials in Puerto Rico have reported the first Zika-related case of microcephaly. The announcement comes on the heels of news of the first Zika-related death in the country just last week.

Charitha Gowda, MD, MPH, infectious diseases physician at Penn Presbyterian Medical Center discusses the impact direct-acting antivirals have had on patients’ adherence to their drug regimen when treating hepatitis C.

Rohit Bhalla, DO, Chief of the Section of Infectious Diseases at the University Medical Center of Princeton, discusses a concerning trend among individuals to purposefully infect themselves with the Zika virus, in the hopes of building up an immunity.

Charitha Gowda, MD, MPH, Infectious diseases physician at Penn Presbyterian Medical Center explains how the treatment regimen for treating those with acute hepatitis C differs from chronic hepatitis C.

The Centers for Disease Control and Prevention (CDC) just released updated guidance for Zika diagnostic testing.

Rohit Bhalla, DO, Chief of the Section of Infectious Diseases at the University Medical Center of Princeton, shares what other diseases could be mistaken for a Zika virus infection.

Charitha Gowda, MD, MPH, Infectious diseases physician at Penn Presbyterian Medical Center explains the process for the evaluation of hepatitis C, leading up to treatment.

Rohit Bhalla, DO, Chief of the Section of Infectious Diseases at the University Medical Center of Princeton, discusses if we will see more vaccine-preventable diseases in the United States in the future.

Charitha Gowda, MD, MPH, discusses the current and upcoming methods to prevent hepatitis C.

Rohit Bhalla, DO, Chief of the Section of Infectious Diseases at the University Medical Center of Princeton, explains the current guidelines for women with regards to pregnancy and the Zika virus.

Rohit Bhalla, DO, Chief of the Section of Infectious Diseases at the University Medical Center of Princeton, shares how healthcare practitioners can help stop the spread of mumps.

Consumers should note that the recalled products may have been purchased in all fifty US states and select provinces in Canada: British Colombia, Alberta, Manitoba, and Saskatchewan.